VasculoTox, Inc

At VasculoTox, Inc., an emerging biotech, our research objectives include the development of assays for diagnostic and therapeutic applications - including both sophisticated high-throughput applications and point-of-care (POC) diagnostic assay development for practical applications. Assay development of comprehensive panels of potential biomarkers (clinical classification) and therapeutic targets (existing or novel drugs for target identification, validation and modulation) can afford the development of diagnostic tools and precision-medicine therapies. The development of POC diagnostic assays can allow for an affordable and rapid approach for measurements that can be assessed frequently for the purposes of early detection (preclinical and prodromal stages) and disease progression.

-
New York, NY
innovation@vasculotox.com
http://www.vasculotox.com

AssaysDiagnosticsGenomics